Skip to content
DustHazardAnalysis.ca
Menu

Pharmaceutical Dust Hazard Analysis

What a DHA looks at in drug, nutraceutical and natural health product plants, where solvents, inerting and new ingredients change the picture.

Estimate your cost

Would you like to get pricing for the following equipment that will likely be required as a result of your study?

A pharmaceutical dust hazard analysis looks at the powders a drug, nutraceutical or natural health product plant mills, blends, granulates, dries, presses and fills, and at the dust collectors and containment systems around them. Batches are often small and products change often, so the analysis has to keep up with new ingredients, and solvents or inerted equipment can add hazards that a plain powder plant does not have.

What does a pharmaceutical dust hazard analysis cover?

A pharmaceutical dust hazard analysis covers each powder handled, each process step from dispensing and milling to blending, drying, compression and filling, the collectors and containment that serve them, and the ignition sources, solvents and inert gas systems nearby.

Many active ingredients, excipients and nutraceutical powders are fine organic materials. Whether a given powder is a combustible dust is settled by testing or published data, which is why a new product often starts with the combustible dust testing step.

What should a pharmaceutical DHA look at first?

A pharmaceutical DHA should look first at powders with no test data, solvent use near powders, inerted equipment, dust collectors and containment, and whether safety data sheets name the dust hazard, and five questions sort those out.

Where to start in a pharmaceutical or nutraceutical plant: 5 questions

  1. Is the powder new to the plant, or are its dust test results missing?Yes: Plan for testing or published data first; in BC, from January 4, 2027, a dust is assumed ignitable and deflagrable until shown otherwise.No: Go to question 2, using the results on file.
  2. Are flammable solvents used near the powder, for example in granulation or coating?Yes: The hazardous location classification has to cover both explosive gas and explosive dust areas.No: Go to question 3.
  3. Is any equipment inerted, for example blanketed with nitrogen?Yes: The DHA confirms the oxygen limit the inerting holds and what happens if it fails; NFPA 69 covers oxidant concentration reduction.No: Go to question 4.
  4. Does a dust collector or containment system serve the line?Yes: The collector is a priority in the DHA; in an Ontario factory, a new or modified collector with an ignition or explosion risk may need a pre-start review.No: Go to question 5.
  5. Do the safety data sheets for your powders name the combustible dust hazard?Yes: Keep them with the DHA records.No: Ask the supplier: WHMIS has a Combustible Dusts hazard class under the Hazardous Products Regulations.

Based on BC's OHS Regulation, ESA Bulletin 18-1-21, NFPA 69, Ontario's Regulation 851 and the Hazardous Products Regulations. The engineer confirms the answers for your plant.

Which rules apply to pharmaceutical and nutraceutical plants?

Pharmaceutical and nutraceutical plants are covered by the general combustible dust rules, since none of the Canadian rules covered here names them: the fire code's dust section, provincial workplace rules, the electrical code for classified areas, and WHMIS.

Where solvents and powders meet, ESA's Bulletin 18-1-21 describes classification for areas with explosive gases or dust, done by a licensed professional engineer; the hazardous location classification overview covers it. NFPA 660's 2025 edition also adds evaluation of self-heating and thermal instability, which matters for some active ingredients.

What do dust investigations say about pharmaceutical plants?

The US Chemical Safety Board's 2006 combustible dust study listed pharmaceuticals with aluminum casting, plastics and wood products as industries particularly at risk for dust explosions, and recommended targeted inspection of them.

Its investigation of the 2003 explosion at West Pharmaceutical Services, a maker of rubber parts for pharmaceutical devices, found polyethylene powder gathered above a suspended ceiling in a plant whose visible production areas were kept very clean; the plastics, rubber and chemicals page covers that case.

Who needs a pharmaceutical dust hazard analysis, and where are the plants?

Drug manufacturers, contract manufacturers, and nutraceutical and natural health product makers with milling, blending, drying or dust collection need a pharmaceutical dust hazard analysis, and Statistics Canada counts most of these plants in Ontario.

Of the 431 pharmaceutical and medicine manufacturers with employees in Canada in 2025, 179 are in Ontario, 65 in British Columbia and 29 in Alberta, according to Statistics Canada data on Innovation, Science and Economic Development Canada's industry statistics site.

How does a pharmaceutical DHA differ from one for a bulk powder plant?

A pharmaceutical DHA deals with many small batches and changing ingredients, solvent and powder areas side by side, and inert gas systems, while a bulk powder plant usually has a few large, steady processes with one main dust.

The dust hazard analysis page describes the study itself, and explosion venting design covers protection for collectors and dryers.

Back to the combustible dust industries overview.

What does a pharmaceutical dust hazard analysis cost, and how long does it take?

Drug and nutraceutical plants pay from $8,000–$15,000 before HST for a pharmaceutical dust hazard analysis covering a single line or collector, and the engineer's report typically arrives 4–8 weeks after go-ahead, or 3–6 weeks later when new ingredients need laboratory testing.

Dust hazard analysis, one process or dust collection system$8,000–$15,000Starting range, before HST. The estimator on this page gives a range for your own facility.

This page's estimator opens with a dust hazard analysis and pharmaceutical dust. See the price table for every study and the regulations by province page for provincial rules.

Pharmaceutical and nutraceutical dust questions

Are nutraceutical powders combustible?

Many nutraceutical and natural health product powders are organic and can be combustible dusts, and only a test or published data settles it for a given powder. In BC, section 6.137 has a dust treated as ignitable and deflagrable until a written determination shows otherwise, from January 4, 2027.

Does inerting remove the need for a DHA?

Inerting does not remove the need for a DHA; the analysis confirms the oxygen limit the system holds and what happens if it fails. NFPA 69 covers deflagration prevention by oxidant concentration reduction in Chapter 7, with an annex on limiting oxidant concentrations.

How often should a pharmaceutical DHA be updated?

A pharmaceutical DHA should be updated at least every five years and whenever a new ingredient, process or piece of equipment comes in. NFPA 652 sets the five-year review, and in BC section 6.140 (3) requires the assessment to be updated after a significant change.

What happens if a new ingredient is never tested?

An untested ingredient leaves the DHA working from assumptions, and in BC the rule fills the gap by treating the dust as ignitable and deflagrable. Sections 6.137 to 6.139 of BC’s OHS Regulation set that from January 4, 2027.

Sources

  1. Investigation Report: Combustible Dust Hazard Study (Report No. 2006-H-1) (opens in a new tab), U.S. Chemical Safety and Hazard Investigation Board.
  2. Hazardous Products Regulations (SOR/2015-17), Subpart 17 Combustible Dusts and Schedule 5 (opens in a new tab), Government of Canada, Justice Laws.
  3. Approved amendments for Part 6, Combustible Dusts, in the Occupational Health and Safety Regulation and the Prevention Manual (opens in a new tab), WorkSafeBC.
  4. NFPA 69, Standard on Explosion Prevention Systems (opens in a new tab), National Fire Protection Association.
  5. OESC Bulletin 18-1-21: Classification of hazardous locations (opens in a new tab), Electrical Safety Authority.
  6. R.R.O. 1990, Reg. 851: Industrial Establishments (sections 7 and 63 to 65) (opens in a new tab), Government of Ontario, e-Laws.
  7. NFPA 660, Standard for Combustible Dusts and Particulate Solids (opens in a new tab), National Fire Protection Association.
  8. NFPA 652, Combustible Dust Awareness and Hazard Evaluation (online training series) (opens in a new tab), National Fire Protection Association.
  9. Canadian Industry Statistics, Pharmaceutical and medicine manufacturing (NAICS 3254): establishments (Statistics Canada data) (opens in a new tab), Innovation, Science and Economic Development Canada.